enVVeno Medical Corp. (NVNO)
6.65
-0.26
(-3.76%)
USD |
NASDAQ |
Oct 23, 16:00
6.60
-0.05
(-0.75%)
After-Hours: 20:00
enVVeno Medical Net Income (Quarterly) : -3.60M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.60M |
| March 31, 2026 | -3.849M |
| December 31, 2025 | -3.736M |
| September 30, 2025 | -4.539M |
| June 30, 2025 | -6.694M |
| March 31, 2025 | -4.503M |
| December 31, 2024 | -6.229M |
| September 30, 2024 | -5.642M |
| June 30, 2024 | -4.956M |
| March 31, 2024 | -4.992M |
| December 31, 2023 | -5.649M |
| September 30, 2023 | -5.001M |
| June 30, 2023 | -6.474M |
| March 31, 2023 | -6.392M |
| December 31, 2022 | -6.18M |
| September 30, 2022 | -6.097M |
| June 30, 2022 | -7.062M |
| March 31, 2022 | -5.33M |
| December 31, 2021 | -8.988M |
| Date | Value |
|---|---|
| September 30, 2021 | -2.389M |
| June 30, 2021 | -2.378M |
| March 31, 2021 | -2.773M |
| December 31, 2020 | -4.374M |
| September 30, 2020 | -1.975M |
| June 30, 2020 | -1.627M |
| March 31, 2020 | -1.160M |
| December 31, 2019 | -2.291M |
| September 30, 2019 | -1.815M |
| June 30, 2019 | -1.946M |
| March 31, 2019 | -1.574M |
| December 31, 2018 | -1.782M |
| September 30, 2018 | -1.468M |
| June 30, 2018 | -5.045M |
| March 31, 2018 | -4.748M |
| December 31, 2017 | -3.124M |
| September 30, 2017 | -2.255M |
| December 31, 2016 | -1.540M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.60M |
| EPS Diluted (Quarterly) | -5.365 |
| Enterprise Value | -16.51M |
| Earnings Yield | -376.6% |
| Normalized Earnings Yield | -373.50 |